|
1) Chan PH, Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab. 2001; 21: 2-14
|
|
|
|
2) Li F, Hayashi T, Jin G, et al. The protective effect of dantrolene on ischemic neuronal cell death is associated with reduced expression of endoplasmic reticulum stress markers. Brain Res. 2005; 1048: 59-68
|
|
|
|
|
3) Abe K, Yuki S, Kogure K. A strong attenuation of ischemic and postischemic brain edema by a novel free radical scavenger. Stroke. 1988; 19: 480-5
|
|
|
|
|
|
4) Nishi H, Watanabe T, Sakurai H, et al. Effect of MCI-186 on brain edema in rats. Stroke. 1989; 20: 1236-40
|
|
|
|
|
|
5) Zhang WR, Sato K, Hayashi T, et al. Extension of ischemic therapeutic time window by a free radical scavenger, Edaravone, reperfused with tPA in rat brain. Neurol Res. 2004; 26: 342-8
|
|
|
|
|
|
6) The Edaravone Acute Brain Infarction Study Group(Chair: Otomo E). Effect of a novel free radical scavenger, Edaravone(MCI-186) on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters. Cerebrovasc Dis. 2003; 15: 222-9
|
|
|
|
|
|
7) Abe K, Pan LH, Watanabe M, et al. Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of ALS. Neurosci Lett. 1995; 199: 152-4
|
|
|
|
|
|
8) Beal MF. Mitochondria take center stage in aging and neurodegeneration. Ann Neurol. 2005; 58: 495-505
|
|
|
|
|
|
9) Warita H, Hayashi T, Murakami T, et al. Oxidative damage to mitochondrial DNA in spinal motoneurons of transgenic ALS mice. Mol Brain Res. 2001; 89: 147-52
|
|
|
|
|
|
10) Kaal EC, Vlug AS, Versleijen MW, et al. Chronic mitochondrial inhibition induces selective motoneuron death in vitro: a new model for ALS. J Neurochem. 2000; 74: 1158-65
|
|
|
|
|
|
11) Oosthuyse B, Moons L, Storkebaum E, et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet. 2001; 28: 131-8
|
|
|
|
|
|
12) Murakami T, Ilieva H, Shiote M, et al. Hypoxic induction of VEGF is selectively impaired in mice carrying the mutant SOD1 gene. Brain Res. 2003; 989: 231-7
|
|
|
|
|
|
13) Ilieva H, Nagano I, Murakami T, et al. Sustained induction of survival p-AKT and p-ERK signals after transient hypoxia in mice spinal cord with G93A mutant human SOD1 protein. J Neurol Sci. 2003; 215: 57-62
|
|
|
|
|
|
14) Manabe Y, Nagano I, Gazi MS, et al. Adenovirus-mediated gene transfer of glial cell line-derived neurotrophic factor prevents motor neuron loss of transgenic model mice for ALS. Apoptosis. 2002; 7: 329-34
|
|
|
|
|
|
15) Nagano I, Ilieva H, Shiote M, et al. Therapeutic benefit of intrathecal injection of insulin-like growth factor-1 in a mouse model of Amyotrophic Lateral Sclerosis. J Neurol Sci. 2005; 235: 61-8
|
|
|
|
|
|
16) Nagano I, Shiote M, Murakami T, et al. Beneficial effects of intrathecal IGF-1 administration in patients with amyotrophic lateral sclerosis. Neurol Res. 2005; 27: 768-72
|
|
|
|
|
|
17) Sun W, Funakoshi H, Nakamura T. Overexpression of HGF retards disease progression and prolongs life span in a transgenic mouse model of ALS. J Neurosci. 2002; 22: 6537-48
|
|
|
|
|
|
18) Yoshino H, Kimura A. Investigation of the therapeutic effects of edaravone, a free radical scavenger, on amyotrophic lateral sclerosis (Phase II study). ALS. 2006; 7: 241-5
|
|
|
|
|